Exploring Uncertainty in Economic Evaluation of Medicines: A Review of the First Manufacturers' Submissions to the French National Authority for Health (Has)

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prm112 - Incorporation of Anti-Cancer Drugs Adverse Events in Health Economic Opinions of the French National Authority for Health (Has)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Use of Budget Impact Analysis (Bia) in Economic Evaluations of Drugs and Medical Devices Submitted to the French National Authority for Health (Has)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Methodological Analyses of Budget Impact Models Submitted to the Haute Autorité De Santé (HAS) (French National Authority for Health)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Exploration of the Difference in Results of Economic Submissions to the National Institute of Clinical Excellence by Manufacturers and Assessment Groups

International Journal of Technology Assessment in Health Care
Health Policy
2007English

Prm67 - Utilities in Oncology Submissions Submitted to Nice —Approach of the Manufacturers

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

From Foreign to National: A Review of the Status of the French Language in Gabon

Literator
LinguisticsLiteratureLiterary TheoryLanguage
2011English

PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health Insurance

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

National Medicines Policies – A Review of the Evolution and Development Processes

Journal of Pharmaceutical Policy and Practice
ToxicologyPharmaceuticsPharmacologyHealth Policy
2013English

Analysis of Assortiment of Medicines for the Treatment of Benign Prostate Diseases for the Evaluation of Particular Marketing Opportunities for Domestic Manufacturers

ScienceRise: Pharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy